FDA Clearance Tracker · K252072
Francisella tularensis Real-time PCR assay
Last checked: Nov 19, 2026Latest source record: Sep 30, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Sep 30, 2025
Substantially Equivalent
Time to decision
91 days
Received Jul 1, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K252072
- Device name
- Francisella tularensis Real-time PCR assay
- Applicant location
- Atlanta, GA
- Received
- Jul 1, 2025
- Decided
- Sep 30, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.4000
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code SGA (Biothreat Microbial Agent Nucleic Acid Detection Test).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K252072
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Centers for Disease Control and Prevention
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262368 · Decided Oct 7, 2026 · 89 days after receipt
Device type: Assay, Nucleic Acid Amplification, Bacillus Anthracis (NHT) · Laboratory Medicine & Pathology
K263035 · Decided Sep 30, 2026 · 30 days after receipt
Device type: Influenza A And Influenza B Multiplex Nucleic Acid Assay (OZE) · Laboratory Medicine & Pathology
K260812 · Decided Mar 30, 2026 · 17 days after receipt
Device type: Biothreat Microbial Agent Nucleic Acid Detection Test (SGA) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.